This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Knowing where to invest for retirement in your 40s is essential. Uncover top investment opportunities that align with your goals.
17,541 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Regulatory headlines have a way of rattling investors, especially in high-growth tech sectors. This article dives int...
Rockwell Medical is a niche player in renal care. This analysis breaks down rockwell medical (rmti) earnings, what th...
Copper prices sit near multi-month highs in March 2026, and investors are eyeing a Chile-focused ETF as a clean coppe...
A clear, investor-focused read on what The Trade Desk's Q1 2026 results mean for 2026. Discover growth drivers, margi...
Oil sits around $107.70 a barrel on May 11, 2026, supported by producer discipline and steady demand. The move could ...
A hantavirus outbreak can spark biotech chatter, but three solid realities—limited demand, tough development paths, a...
A standard checking account with near-zero yields can quietly erode a $30,000 emergency fund over ten years. By movin...
UiPath faced a cautious session as its Korea cloud launch tests regional demand. This article breaks down what happen...
When a CFO sells shares after exercising options, investors want the real story. This article explains what ambiq mic...
Abercrombie & Fitch shares surged after a stronger-than-expected quarter. This article breaks down the factors behind...
Alaska Air Group stock surged this week as investors weighed fuel-cost pressures against resilient demand and discipl...